Almost 90% of the funding went to external research projects, the Federal Statistical OfficeExternal link reported. The remaining 10% of the money went on internal research by federal authorities themselves – notably the Agroscope institute, which conducts research into agriculture.
A good half of the total went to universities and the Swiss National Science Foundation (SNSF), which supports and coordinates national research projects running over several years, and in various academic disciplines, from the natural to the social sciences.
A total of CHF850 million was earmarked for projects outside Switzerland, including key European Union research programmes and the European Space Agency. The European Organization for Nuclear Research (CERN), based near Geneva, received CHF47 million from the Swiss.
All told, the funding marked a 12% increase compared with 2017, the last time such figures were available.
By international comparisonExternal link, according to the Organisation for Economic Cooperation and Development (OECD), “Switzerland has above-average spending on research and development, a factor which (along with others) means that it has the second highest rate of doctoral qualifications in the OECD.
In 2018, the OECD writes, 3.2% of Swiss adults held a doctorate.
More
More
The latest in Swiss research, in your inbox
This content was published on
Stay on top of the latest scientific developments out of Switzerland by subscribing to our e-mail newsletter.
Swiss invention: 90-year anniversary of first T-bar ski lift
This content was published on
On Monday it will be 90 years since the world’s first T-bar ski lift went into service in Davos. This Swiss invention was an instant success.
Iran summons Swiss ambassador over US and Italy arrests
This content was published on
Iran has summoned the Swiss ambassador, who represents US interests, to protest against the arrest in the US and Italy of two Iranians.
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Switzerland launches six new science research centres
This content was published on
The new National Centres of Competence in ResearchExternal link (NCCR), designed to have a maximum shelf life of 12 years, will be set up at separate universities around Switzerland. Their focus will be spread among a variety of topics, such as combating antibiotic-resistant bacteria, researching the evolution of language, and developing CO2-neutral solutions for the…
Swiss government launches Covid-19 scientific taskforce
This content was published on
The “Covid-19 taskforce” will be led by Matthias Egger, president of the national research council of the Swiss National Science Foundation (SNSF), the government announcedExternal link on Tuesday. The group will advise the government, interior ministry and other relevant federal and cantonal authorities. It will also identify areas of research and special measures or products…
This content was published on
People in Switzerland have a positive view of science, with climate and energy considered the most important areas for research.
This content was published on
Swiss scientists and drug companies are playing an important role in the global effort to develop treatments or a vaccine for the virus.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.